David Fredrickson

Executive Vice-President, Oncology Business Unit, AstraZeneca

Dave Fredrickson was appointed Executive Vice-President, Oncology Business Unit (OBU) in October 2017 and is responsible for driving growth and maximising the commercial performance of the AstraZeneca global oncology portfolio. In addition, Dave plays a critical leadership role defining and delivering the oncology strategy for the company with accountability for marketing, sales, medical affairs and market access both globally and in major markets. Dave serves as the executive lead for AstraZeneca’s North American Inclusion & Diversity strategy, as well as for the company’s Health Equity Advisory Council where he works with a diverse group of external experts to advance health equity in the U.S. Since joining AstraZeneca in 2014, Dave has held several leadership positions of increasing responsibility, including Vice President, Specialty Care for AstraZeneca in the U.S. and President of AstraZeneca K. K. in Japan. Before joining AstraZeneca, Dave worked at Roche/Genentech, where he served in several functions and leadership positions, including Oncology Business Unit Manager in Spain and strategy, marketing and sales roles in the U.S. Before joining Roche/Genentech, Dave worked at the Monitor Group, LLC (now Monitor Deloitte Group, LLC), a global strategy consultancy. Dave is a graduate of Georgetown University in Washington, DC.

最新記事

ヘルスとヘルスケア

人类正离终结癌症目标越来越近

1971时任美国总统尼克松发起了抗癌战争”。他说:“是时候将我们分裂原子把人类带到月球的集体力量转向到战胜这种可怕的疾病上了。”事实证明对人类来在克服癌症上实现登月级的飞跃远比尼尔·阿姆斯特朗在月球上迈出第一步更难。50多年随着美国总统拜登号召加快抗癌工作进展我们更加关注癌症早期监测技术创新以及公部门间的创造性合我们现在处在有史以来最接近实...

2023年01月29日

世界経済フォーラムについて

エンゲージメント

  • サインイン
  • パートナー(組織)について
  • 参加する(個人、組織)
  • プレスリリース登録
  • ニュースレター購読
  • 連絡先 (英語のみ)

リンク

言語

プライバシーポリシーと利用規約

サイトマップ

© 2024 世界経済フォーラム